ResMed Inc.ResMed Inc.ResMed Inc.

ResMed Inc.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪28.16 B‬CHF
7.815CHF
‪1.11 B‬CHF
‪4.08 B‬CHF
‪145.05 M‬
Beta (1Y)
0.70
Employees (FY)
‪10.6 K‬
Change (1Y)
+620 +6.21%
Revenue / Employee (1Y)
‪385.20 K‬CHF
Net income / Employee (1Y)
‪104.84 K‬CHF

About ResMed Inc.


CEO
Michael J. Farrell
Website
Headquarters
San Diego
Founded
1989
Identifiers
3
ISINUS7611521078
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Check out other big names from the same industry as RME.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
VTI
Vanguard Total Stock Market ETF
Weight
0.06%
Market value
‪1.18 B‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.06%
Market value
‪946.78 M‬
USD
VO
Vanguard Mid-Cap ETF
Weight
0.41%
Market value
‪825.94 M‬
USD
VUG
Vanguard Growth ETF
Weight
0.14%
Market value
‪497.93 M‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.06%
Market value
‪460.36 M‬
USD
SPY
SPDR S&P 500 ETF
Weight
0.06%
Market value
‪429.62 M‬
USD
SPY
SPDR S&P 500 ETF Trust
Weight
0.06%
Market value
‪429.62 M‬
USD
VOT
Vanguard Mid-Cap Growth ETF
Weight
1.00%
Market value
‪322.36 M‬
USD
XLV
State Street Health Care Select Sector SPDR ETF
Weight
0.63%
Market value
‪252.70 M‬
USD
VIG
Vanguard Dividend Appreciation ETF
Weight
0.17%
Market value
‪204.47 M‬
USD
IHI
iShares U.S. Medical Devices ETF
Weight
4.19%
Market value
‪171.72 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of RME is 225.332 CHF — it has increased by 26.85% in the past 24 hours. Watch ResMed Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ResMed Inc. stocks are traded under the ticker RME.
We've gathered analysts' opinions on ResMed Inc. future price: according to them, RME price has a max estimate of 272.08 CHF and a min estimate of 177.44 CHF. Watch RME chart and read a more detailed ResMed Inc. stock forecast: see what analysts think of ResMed Inc. and suggest that you do with its stocks.
RME reached its all-time high on Sep 7, 2021 with the price of 273.388 CHF, and its all-time low was 129.531 CHF and was reached on Nov 14, 2023. View more price dynamics on RME chart.
See other stocks reaching their highest and lowest prices.
RME stock is 21.17% volatile and has beta coefficient of 0.70. Track ResMed Inc. stock price on the chart and check out the list of the most volatile stocks — is ResMed Inc. there?
Today ResMed Inc. has the market capitalization of ‪28.14 B‬, it has increased by 2.68% over the last week.
Yes, you can track ResMed Inc. financials in yearly and quarterly reports right on TradingView.
ResMed Inc. is going to release the next earnings report on Jan 22, 2026. Keep track of upcoming events with our Earnings Calendar.
RME earnings for the last quarter are 2.03 CHF per share, whereas the estimation was 2.00 CHF resulting in a 1.32% surprise. The estimated earnings for the next quarter are 2.15 CHF per share. See more details about ResMed Inc. earnings.
ResMed Inc. revenue for the last quarter amounts to ‪1.06 B‬ CHF, despite the estimated figure of ‪1.06 B‬ CHF. In the next quarter, revenue is expected to reach ‪1.10 B‬ CHF.
RME net income for the last quarter is ‪277.61 M‬ CHF, while the quarter before that showed ‪301.26 M‬ CHF of net income which accounts for −7.85% change. Track more ResMed Inc. financial stats to get the full picture.
Yes, RME dividends are paid quarterly. The last dividend per share was 0.48 CHF. As of today, Dividend Yield (TTM)% is 0.92%. Tracking ResMed Inc. dividends might help you take more informed decisions.
ResMed Inc. dividend yield was 0.82% in 2025, and payout ratio reached 22.30%. The year before the numbers were 1.00% and 27.75% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2025, the company has ‪10.6 K‬ employees. See our rating of the largest employees — is ResMed Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ResMed Inc. EBITDA is ‪1.59 B‬ CHF, and current EBITDA margin is 37.37%. See more stats in ResMed Inc. financial statements.
Like other stocks, RME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ResMed Inc. stock right from TradingView charts — choose your broker and connect to your account.